Tutorial

Use of informative priors in model-informed drug development

Thursday 16 October, 2025

Objectives: To introduce methods for constructing informative priors from historical data or by elicitation from experts To discuss different methods…

Read more

Some considerations concerning covariates in clinical trials

Thursday 16 October, 2025

The closer you get to registration in drug development, the greater the resistance to using covariate information. There is a…

Read more

Implementing Receptor Theory in PK-PD Modeling

Thursday 16 October, 2025

Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) models differ from conventional PK-PD models in that they quantitatively characterize specific processes on the causal path…

Read more

Validation of statistically reliable biomarkers

Thursday 16 October, 2025

DefinitionsBiomarkers play an increasing role in the development of new cancer treatments. A biomarker is defined as "a characteristic that…

Read more

Handling within-subject/between-occasion variability in longitudinal data: Common Challenges and Practical Solutions

Thursday 16 October, 2025

One of the main features of nonlinear mixed-effects models (NLME), and arguably the most powerful one, is their ability to…

Read more

Mixed models for the analysis of categorical repeated measures

Thursday 16 October, 2025

PDF of presentation Whenever a response is measured repeatedly within a set of units (study-participants, animals, patients, …)  correct statistical…

Read more

A Tutorial on Visual Predictive Checks

Thursday 16 October, 2025

The visual predictive check (VPC) is a model diagnostic that can be used to: (i) allow comparison between alternative models,…

Read more